Did you know?

The IWMF raised more than five million dollars for WM medical research

Did you know?

The IWMF raised more than 60 support groups in North America and nearly 20 others world-wide

Did you know?

The IWMF has a current worldwide membership of nearly 4,000

Did you know?

IWMF-TALK is a wonderful place to share information and learn from other survivors

Did you know?

Each year 1,500 new cases of Waldenstrom's macroglobulinemia are diagnosed in the USA

Did you know?

Volunteers at the IWMF Telephone Lifeline are waiting to share their experiences with you

Did you know?

You can order DVD recordings of past WM Educational Forums online or by mail

Did you know?

All IWMF programs and services are funded by WM survivors, caregivers, friends, and family

Research Strategies and Agenda

The IWMF supports the advancement of knowledge in the pathophsysiological basis for the disease Waldenstrom’s macroglobulinemia (WM). This goal is accomplished by providing research grants for basic biomedical research into the origins, clinical manifestations, treatments, and potential future cures for WM.


Since we are a modest non-profit foundation with limited resources and we are virtually 99.9% funded by individual members’ donations, our research strategy focuses on the attentive financial support of programs and institutions which are conscientious and contribute to basic scientific research.


At this time, the IWMF's research strategy supports the following areas:

  1. Basic scientific research into the pathogenesis of WM.
  2. Translational research to discover whether drugs used for similar cancers are effective with WM cells.
  3. Exploratory research on promising new targets for the destruction of WM cells.
  4. The development of representative WM cell lines.
  5. The development of WM mice models.
  6. Meetings and conferences for researchers to encourage open communication and coordination of ongoing research efforts.


Research Grants

The majority of our research funds are for basic biomedical research grants (see the Research Results page), and we do not fund clinical trials.


We have a rigorous process of application which includes evaluation by appropriate WM expert scientists selected from the IWMF Scientific Advisory Committee, approval by the IWMF Research Committee, and, finally, approval by the IWMF Board of Trustees.  We are always interested in applications for new research projects; detailed information on the research grant application process can be found in the section “Applying for a Grant”.


Sponsorships of International Medical Conferences on WM  


In its commitment towards furthering the advancement of research particular to WM, the IWMF has been instrumental in the development and support of international conferences that provide the opportunity for medical professionals to share their research findings and collaborate on methodologies to further advance what's known about WM. 


IWWM8 - Eighth International Workshop on WMAugust 14-17, 2014London, UK

The IWMF will participate in this workshop.


This will be followed by the 5th International IWMF Doctor-Patient Forum on Waldenstrom's Macroglobulinemia which will be held on Sunday, August 17.

IWWM7 - Seventh International Workshop on WMAugust 23-26, 2012Newport, RI, USAThis was essentially the culmination of all the previous IWWM Workshops and included a record number of investigators reporting on the genetic basis, pathogenesis, and treatment of WM.
11th International Conference on Malignant LymphomaJune 15-18, 2011Lugano, SwitzerlandThe IWMF provided funds to help support this conference, and also participated in it.
IWWM6 - Sixth International Workshop on WMOctober, 2010Venice, ItalyAt the conclusion of this Workshop for medical professionals, the Second International Patient Forum was held for European WM patients.
IWWM5 - Fifth International Workshop on WMOctober, 2008Stockholm, SwedenDuring the workshop tribute was paid to the late Dr. Jan Waldenström who discovered the disease. Discussions were held concerning consensus recommendations for treatment regimens made at previous International Workshops. At the conclusion of this Workshop, a seminar featuring doctors who treat WM was held for European WM patients.
IWWM4 - Fourth International Workshop on WMJune, 2007Kos, GreeceThis site was significant in that it was the birthplace of Hippocrates, the “father of medicine.”
10th International Myeloma WorkshopApril 10-14, 2005Sydney, AustraliaA number of papers on WM were presented at this workshop.  
IWWM3 - Third International Workshop on WMOctober, 2004Paris, FranceThis workshop continued the momentum begun by the previous two workshops in expanding our understanding of this rare disease. Fifty-seven investigators representing 13 countries took part in this workshop. Importantly, this meeting included presentations from eleven Young Investigator Award recipients, made possible through the generosity of the IWMF, reflecting continued recruitment of new investigators to both the basic scientific and clinical discovery of Waldenstrom’s macroglobulinemia.
IWWM2 - Second International Workshop on WMSeptember, 2002Athens, GreeceThis workshop saw a significant increase in the number of researchers in attendance, expanded the international exposure, and focused on diagnosis, prognosis, treatment, and the search for a cure.
IWWM1 - First International Workshop on WMSeptember 7-8, 2000Bethesda, MD, USAThis workshop was initiated with the cooperation of the National Cancer Institute, and invited 21 prominent researchers from around the world for a two-day intensive exploration of the treatments for WM.


* For more information about the IWWM workshops, go to: http://www.wmworkshop.org.